Unripe grape juice (verjuice) as a lipid-lowering agent: Fact or fiction

Archives of Iranian Medicine

Volumn 6, Issue 1, 2003, Pages 32-34

  Aminian, Bahram ^a   Massoompour, Seyed Massoom ^a   Sadeghalvaad, Abdossamad ^a   Omrani, Gholam Hossein ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hyperlipidemia; LDL cholesterol; Triglycerides; Unripe grape juice

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; GRAPE EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; GRAPE JUICE; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; STUDENT T TEST; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0037531834     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Consensus Conference. Lowering blood cholesterol to prevent heart disease. JAMA. 1985; 253: 2080-6.
2. Grundy SM. Primary prevention of coronary heart disease: integrating risk assessment with intervention. Circulation. 1999; 100: 988-98.
3. Cohen JD. A population-based approach to cholesterol control. Am J Med. 1997; 102: 23-5.
4. Chen Z, Peto R, Collins R, et al. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ. 1991; 303: 276-82.
5. Denke MA. Diet and lifestyle modification and its relationship to atherosclerosis. Med Clin North Am. 1994; 78: 197-233.
6. Caron MF, White CM. Evaluation of the antihyperlipidemic properties of dietary supplements. Pharmacotherapy. 2001; 21: 481-7.
7. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502.
8. Day AP, Kemp HJ, Bolton C, et al. Effect of concentrated red grape juice consumption on serum antioxidant capacity and low-density lipoprotein oxidation. Ann Nutr Metab. 1997; 41: 353-7.
9. Stein J, Keevil J, Wiebe D, et al. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation. 1999; 100: 1050-5.
10. Vinson J, Teufel K, Wu N. Red wine, dealcoholized red wine and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis. 2001; 156: 67-72.
11. Goldberg DM, Garvoic-Kocic V, Diamandis EP, et al. Wine: does the color count? Clin Chim Acta. 1996; 246: 163-82.
12. Miyagi Y, Miwa K, Inoue H. Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. Am J Cardiol. 1997; 80: 1627-31.
13. Constant J. Alcohol, ischemic heart disease, and French paradox. Clin Cardiol. 1997; 20: 420-4.
14. Luz P, Serano J, Chacra J, et al. The effect of red wine on experimental atherosclerosis: lipid-independent protection. Exp Mol Pathol. 1999; 65: 150-9.